Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Not applicable

The Effect of Different Positions Given to the Newborn During Delayed Cord Clamping on Physiological Indicators and Comfort

NCT07719751 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-11
Last updated
2026-07-22

Condition(s) studied

Newborn InfantNewborn HealthDelayed Cord Clamping

Investigational drug(s) / intervention(s)

Prone positionLeft side lying position

Prone position: After birth, the newborn will be positioned vertically on the linea line above the mother's mons pubis and monitored while lying prone.

Left side lying position: After birth, the newborn will be positioned vertically on the linea line above the mother's mons pubis and monitored while lying left side.

Study summary

During intrauterine life, the fetus is connected to the mother via the placenta; with birth, the extrauterine adaptation process begins. The first six hours after birth are defined as the "adaptation period" for the newborn and consist of three stages. In this process, the first reactive period is particularly critical because the initial assessments determine the newborn's well-being. All organs, especially the respiratory and cardiovascular systems, are rapidly activated, and adaptation parameters are monitored. Evidence-based care interventions applied by midwives during this period directly affect the newborn's physiological stability and long-term health. The timing of umbilical cord clamping is a decisive factor in this adaptation. The World Health Organization recommends waiting at least 1 minute after birth for term and stable preterm infants, ideally with a delay of 1-3 minutes for clamping. Blood flow from the placenta to the baby continues for the first few minutes after birth. Therefore, not clamping the umbilical cord until 2-3 minutes have passed or until the cord pulse has completely stopped provides a physiological blood transfer. In this process, defined as "placental transfusion," a large portion of the blood passes to the baby within the first 3 minutes, contributing to an increase in circulatory volume and hemoglobin levels. In premature infants, stem cell transfer reduces complications and provides long-term benefits. In addition, this practice increases venous return, supporting heart filling and facilitating cardiorespiratory transition. In infants who undergo delayed clamping, oxygen saturation rises faster and irregular heartbeats are less common.

Eligibility

Sex
ALL
Min age
0 Minutes
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * The newborn must have been born at term (≥37 weeks) * Born from a singleton pregnancy * Born vaginally * The newborn must have been born alive * The newborn must have spontaneous breathing * The 1-minute Apgar score must be ≥7 * The mother must be able to communicate with the research * The mother must have volunteered to participate in the study and given informed consent Exclusion Criteria: * Meconium-stained or foul-smelling amniotic fluid * Episiotomy (3rd and 4th degree) and medical intervention during labor (vacuum, dystocia interventions, etc.) * Suspicion of congenital anomalies or genetic diseases in the newborn * History of known chronic diseases in the mother or baby (diabetes, hypertension, epilepsy, thyroid disease, etc.)

Primary outcome measure(s)

  • Heart rate (pulse) — During delayed umbilical cord clamping (within the first minutes after birth)
    Heart rate will be measured using a pulse oximeter during delayed umbilical cord clamping while the newborn is positioned either in the prone or left lateral position.

Trial sites (1)

FacilityCityRegionStatus
Mersin University Mersin Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07719751 on ClinicalTrials.gov ↗ ← All trials in Turkey